Work

A habitat-pathology-clinical transformer model for precision prognostication of neoadjuvant immunochemotherapy in ESCC

Year: 2026
Type: article
Study design: Observational Study
Abstract: Esophageal squamous cell carcinoma (ESCC) shows marked inter-patient heterogeneity in response to neoadjuvant immunochemotherapy (NICT), highlighting the need for reliable pre-treatment predictors. In this multicenter study, 102 patients with advanced ESCC from two institutions were enrolled. Pre-treatment contrast-enhanced CT, whole-slide histopathology images, and clinical data were collected. Habitat-based radiomics was selected as the optimal imaging approach, with a Support Vector Machine (SVM) achieving an AUC of 0.723 (95% CI: 0.580–0.866) in the test cohort. For pathomics, the ResNet50-based multi-instance learning model with logistic regression was selected, achieving an AUC of 0.766 (95% CI: 0.639–0.894). These signatures were integrated with clinical features to develop HPTrans, a transformer-based multimodal model. HPTrans outperformed all single-modality approaches, achieving AUC of 0.921 (95% CI: 0.889–0.952) in the training cohort and 0.824 (95% CI: 0.720–0.928) in the test cohort. Collectively, HPTrans may aid pretreatment NICT response prediction and treatment selection in patients with advanced ESCC.
Source: iScience
Language: English
Field: Medicine
Open Access status: gold
Estimated APC paid: $3,240
OpenAlex ID: W7124745816
FWCI:
Cites: 33
Cited by:
Related to: 10